Continued Access Program for Tumor Treating Fields (TTFields) Used With Chemotherapy (Gemcitabine and Nab-Paclitaxel) in Adults With Locally Advanced Pancreatic Cancer (PANOVA-3CA)

NCT07319910 · clinicaltrials.gov ↗

TEMPORARILY_NOT_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Locally Advanced Pancreatic Adenocarcinoma

Interventions

DEVICE: TTFields
DRUG: Gemcitabine
DRUG: Nab paclitaxel

Sponsor

NovoCure GmbH